Arny Ferrando
Concepts (314)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Muscle Proteins | 43 | 2023 | 307 | 5.970 |
Why?
| Dietary Proteins | 20 | 2022 | 230 | 5.370 |
Why?
| Muscle, Skeletal | 45 | 2023 | 847 | 5.350 |
Why?
| Amino Acids, Essential | 25 | 2022 | 125 | 4.570 |
Why?
| Amino Acids | 18 | 2023 | 369 | 4.510 |
Why?
| Protein Biosynthesis | 12 | 2021 | 273 | 3.070 |
Why?
| Body Composition | 19 | 2023 | 349 | 1.950 |
Why?
| Bed Rest | 8 | 2009 | 39 | 1.920 |
Why?
| Proteins | 8 | 2022 | 376 | 1.860 |
Why?
| Muscular Atrophy | 4 | 2021 | 73 | 1.810 |
Why?
| Dietary Supplements | 15 | 2023 | 449 | 1.780 |
Why?
| Military Personnel | 5 | 2023 | 174 | 1.570 |
Why?
| Phenylalanine | 12 | 2022 | 125 | 1.460 |
Why?
| Exercise | 16 | 2023 | 552 | 1.330 |
Why?
| Quadriceps Muscle | 3 | 2023 | 49 | 1.190 |
Why?
| Isotopes | 3 | 2022 | 24 | 1.130 |
Why?
| Arthroplasty, Replacement, Hip | 4 | 2022 | 251 | 1.100 |
Why?
| Sarcopenia | 4 | 2021 | 83 | 1.100 |
Why?
| Eating | 5 | 2022 | 155 | 1.100 |
Why?
| Aging | 8 | 2021 | 784 | 1.050 |
Why?
| Kidney Failure, Chronic | 8 | 2010 | 231 | 1.050 |
Why?
| Meals | 6 | 2021 | 62 | 1.020 |
Why?
| Feeding Behavior | 3 | 2017 | 200 | 1.010 |
Why?
| Muscle Strength | 7 | 2021 | 132 | 0.980 |
Why?
| Humans | 91 | 2023 | 54284 | 0.960 |
Why?
| Anabolic Agents | 7 | 2019 | 35 | 0.950 |
Why?
| Hydrocortisone | 7 | 2012 | 124 | 0.930 |
Why?
| Renal Dialysis | 7 | 2010 | 192 | 0.930 |
Why?
| Stress, Physiological | 2 | 2019 | 194 | 0.900 |
Why?
| Dietary Carbohydrates | 5 | 2021 | 89 | 0.860 |
Why?
| Male | 60 | 2023 | 27334 | 0.850 |
Why?
| Malnutrition | 2 | 2021 | 83 | 0.770 |
Why?
| Muscle Contraction | 2 | 2019 | 109 | 0.750 |
Why?
| Postoperative Care | 1 | 2021 | 121 | 0.750 |
Why?
| Preoperative Care | 1 | 2021 | 184 | 0.720 |
Why?
| Postprandial Period | 6 | 2021 | 79 | 0.700 |
Why?
| Military Medicine | 1 | 2019 | 21 | 0.700 |
Why?
| Proteome | 1 | 2020 | 178 | 0.680 |
Why?
| Burns | 7 | 2012 | 170 | 0.680 |
Why?
| Energy Metabolism | 8 | 2021 | 311 | 0.660 |
Why?
| Testosterone | 6 | 2022 | 119 | 0.650 |
Why?
| Occupational Diseases | 1 | 2019 | 93 | 0.650 |
Why?
| Adult | 39 | 2022 | 14207 | 0.640 |
Why?
| Breakfast | 1 | 2017 | 16 | 0.620 |
Why?
| Female | 44 | 2023 | 28441 | 0.620 |
Why?
| Aged | 23 | 2022 | 10054 | 0.610 |
Why?
| Nitrogen | 4 | 2022 | 78 | 0.590 |
Why?
| Insulin | 10 | 2021 | 510 | 0.570 |
Why?
| Hormones | 4 | 2019 | 59 | 0.560 |
Why?
| Glucose | 3 | 2021 | 366 | 0.560 |
Why?
| Kinetics | 9 | 2020 | 692 | 0.540 |
Why?
| Middle Aged | 27 | 2022 | 13088 | 0.530 |
Why?
| Diet | 6 | 2022 | 598 | 0.530 |
Why?
| Muscular Diseases | 2 | 2006 | 65 | 0.520 |
Why?
| Cross-Over Studies | 8 | 2022 | 250 | 0.520 |
Why?
| Leucine | 6 | 2023 | 113 | 0.510 |
Why?
| Body Mass Index | 8 | 2021 | 713 | 0.470 |
Why?
| Insulin Resistance | 2 | 2021 | 300 | 0.460 |
Why?
| Liver Transplantation | 3 | 2020 | 160 | 0.460 |
Why?
| Absorptiometry, Photon | 5 | 2023 | 174 | 0.410 |
Why?
| Osteoarthritis | 2 | 2022 | 71 | 0.410 |
Why?
| Triglycerides | 2 | 2009 | 195 | 0.410 |
Why?
| Tyrosine | 3 | 2022 | 137 | 0.400 |
Why?
| Nutritional Requirements | 3 | 2022 | 69 | 0.390 |
Why?
| Nutritional Status | 3 | 2021 | 158 | 0.380 |
Why?
| Cushing Syndrome | 1 | 2009 | 13 | 0.360 |
Why?
| Cytokines | 6 | 2015 | 676 | 0.360 |
Why?
| Homeostasis | 2 | 2014 | 223 | 0.350 |
Why?
| Blood Glucose | 5 | 2017 | 489 | 0.340 |
Why?
| Myositis | 2 | 2022 | 18 | 0.340 |
Why?
| End Stage Liver Disease | 2 | 2020 | 43 | 0.340 |
Why?
| Immobilization | 2 | 2007 | 14 | 0.340 |
Why?
| Metabolism | 4 | 2020 | 28 | 0.330 |
Why?
| Isotope Labeling | 2 | 2019 | 58 | 0.320 |
Why?
| Nutritional Physiological Phenomena | 1 | 2008 | 22 | 0.320 |
Why?
| Resistance Training | 5 | 2015 | 102 | 0.300 |
Why?
| Muscle Fibers, Slow-Twitch | 1 | 2006 | 12 | 0.290 |
Why?
| Muscle Fibers, Fast-Twitch | 1 | 2006 | 14 | 0.290 |
Why?
| Glucose Transport Proteins, Facilitative | 1 | 2006 | 10 | 0.290 |
Why?
| Food, Formulated | 3 | 2019 | 44 | 0.290 |
Why?
| Liver Cirrhosis | 2 | 2020 | 216 | 0.290 |
Why?
| Caloric Restriction | 2 | 2020 | 37 | 0.280 |
Why?
| Biopsy, Needle | 2 | 2015 | 195 | 0.270 |
Why?
| Food | 2 | 2020 | 67 | 0.270 |
Why?
| Infusions, Intravenous | 2 | 2021 | 231 | 0.270 |
Why?
| Ecchymosis | 1 | 2004 | 8 | 0.260 |
Why?
| Blood Specimen Collection | 1 | 2004 | 39 | 0.250 |
Why?
| Hematoma | 1 | 2004 | 60 | 0.250 |
Why?
| Energy Intake | 4 | 2022 | 196 | 0.240 |
Why?
| Catheterization | 1 | 2004 | 108 | 0.240 |
Why?
| Fibrinogen | 1 | 2004 | 37 | 0.240 |
Why?
| Albumins | 1 | 2004 | 38 | 0.240 |
Why?
| Basal Metabolism | 2 | 2020 | 36 | 0.240 |
Why?
| Amino Acid Transport Systems | 1 | 2003 | 6 | 0.240 |
Why?
| Body Weight | 3 | 2018 | 578 | 0.240 |
Why?
| Double-Blind Method | 6 | 2021 | 742 | 0.240 |
Why?
| Glutamic Acid | 1 | 2004 | 111 | 0.230 |
Why?
| Digestion | 2 | 2020 | 51 | 0.230 |
Why?
| Proteolysis | 2 | 2020 | 102 | 0.230 |
Why?
| Quality of Life | 4 | 2022 | 922 | 0.220 |
Why?
| Biological Availability | 2 | 2019 | 131 | 0.220 |
Why?
| Oxandrolone | 3 | 2011 | 10 | 0.220 |
Why?
| Urea | 1 | 2022 | 83 | 0.220 |
Why?
| GTP-Binding Proteins | 1 | 2022 | 94 | 0.210 |
Why?
| Menopause | 1 | 2023 | 61 | 0.210 |
Why?
| Obesity | 2 | 2021 | 1202 | 0.210 |
Why?
| Reindeer | 1 | 2021 | 4 | 0.210 |
Why?
| Egg Proteins | 2 | 2021 | 19 | 0.210 |
Why?
| Overweight | 2 | 2021 | 240 | 0.210 |
Why?
| Sports | 1 | 2022 | 52 | 0.200 |
Why?
| Exercise Therapy | 2 | 2020 | 123 | 0.200 |
Why?
| Postoperative Complications | 2 | 2021 | 1033 | 0.200 |
Why?
| Food Analysis | 1 | 2021 | 37 | 0.200 |
Why?
| Actinidia | 1 | 2020 | 7 | 0.190 |
Why?
| Young Adult | 10 | 2021 | 4318 | 0.190 |
Why?
| Osteoarthritis, Knee | 1 | 2022 | 105 | 0.190 |
Why?
| Cross-Sectional Studies | 2 | 2023 | 1693 | 0.190 |
Why?
| Hyperammonemia | 1 | 2020 | 18 | 0.190 |
Why?
| Hyperphagia | 1 | 2020 | 11 | 0.190 |
Why?
| Hepatic Encephalopathy | 1 | 2020 | 24 | 0.190 |
Why?
| Ketoconazole | 2 | 2012 | 17 | 0.190 |
Why?
| Fatty Acids, Omega-3 | 1 | 2020 | 29 | 0.190 |
Why?
| Orthopedic Procedures | 1 | 2021 | 82 | 0.190 |
Why?
| Mitochondria, Muscle | 1 | 2020 | 46 | 0.190 |
Why?
| Carbohydrate Metabolism | 1 | 2019 | 31 | 0.180 |
Why?
| Metabolomics | 1 | 2021 | 149 | 0.180 |
Why?
| Mitochondrial Proteins | 1 | 2020 | 121 | 0.180 |
Why?
| Risk Assessment | 1 | 2004 | 1361 | 0.180 |
Why?
| Liver Diseases | 1 | 2020 | 87 | 0.170 |
Why?
| Whole Body Imaging | 1 | 2019 | 25 | 0.170 |
Why?
| Receptors, Tumor Necrosis Factor | 2 | 2018 | 36 | 0.170 |
Why?
| Occupational Health | 1 | 2019 | 74 | 0.170 |
Why?
| Altitude Sickness | 1 | 2018 | 8 | 0.170 |
Why?
| Home Care Services | 1 | 2020 | 79 | 0.170 |
Why?
| Autophagy | 1 | 2020 | 202 | 0.160 |
Why?
| Motor Activity | 3 | 2010 | 247 | 0.160 |
Why?
| Diet, High-Fat | 1 | 2020 | 216 | 0.160 |
Why?
| Arthroplasty, Replacement, Knee | 1 | 2022 | 282 | 0.160 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2004 | 486 | 0.160 |
Why?
| Altitude | 1 | 2018 | 17 | 0.160 |
Why?
| Sex Factors | 1 | 2020 | 767 | 0.160 |
Why?
| Leg | 3 | 2011 | 130 | 0.160 |
Why?
| Waiting Lists | 1 | 2018 | 49 | 0.160 |
Why?
| Inflammation | 3 | 2022 | 674 | 0.160 |
Why?
| Time Factors | 5 | 2021 | 3213 | 0.150 |
Why?
| Models, Biological | 3 | 2007 | 823 | 0.150 |
Why?
| Cardiovascular Diseases | 1 | 2021 | 476 | 0.130 |
Why?
| Osteoarthritis, Hip | 1 | 2015 | 28 | 0.130 |
Why?
| Age Factors | 3 | 2014 | 1198 | 0.130 |
Why?
| Risk Factors | 2 | 2019 | 3935 | 0.130 |
Why?
| Beverages | 2 | 2019 | 83 | 0.120 |
Why?
| Gene Expression | 3 | 2006 | 664 | 0.120 |
Why?
| Heart Failure | 1 | 2019 | 541 | 0.110 |
Why?
| Caspase 3 | 2 | 2010 | 135 | 0.110 |
Why?
| Weight Loss | 2 | 2018 | 271 | 0.110 |
Why?
| Adolescent | 7 | 2020 | 6897 | 0.110 |
Why?
| Fasting | 2 | 2020 | 76 | 0.100 |
Why?
| Biopsy | 5 | 2020 | 692 | 0.100 |
Why?
| Glucose Clamp Technique | 1 | 2009 | 19 | 0.090 |
Why?
| Glycerol | 1 | 2009 | 22 | 0.090 |
Why?
| Animals | 3 | 2021 | 14385 | 0.090 |
Why?
| Arginine | 2 | 2008 | 182 | 0.090 |
Why?
| Fatty Acids, Nonesterified | 1 | 2009 | 55 | 0.090 |
Why?
| Protein-Energy Malnutrition | 1 | 2009 | 16 | 0.090 |
Why?
| Athletes | 2 | 2022 | 116 | 0.090 |
Why?
| Exercise Test | 2 | 2020 | 151 | 0.090 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 151 | 0.090 |
Why?
| Oxidation-Reduction | 2 | 2021 | 382 | 0.090 |
Why?
| Hypertriglyceridemia | 1 | 2008 | 17 | 0.080 |
Why?
| Linear Models | 1 | 2009 | 309 | 0.080 |
Why?
| Administration, Oral | 3 | 2009 | 459 | 0.080 |
Why?
| Milk Proteins | 1 | 2009 | 76 | 0.080 |
Why?
| Signal Transduction | 2 | 2020 | 1753 | 0.080 |
Why?
| Liver | 2 | 2018 | 1225 | 0.080 |
Why?
| Oxidative Stress | 2 | 2020 | 958 | 0.080 |
Why?
| Analysis of Variance | 1 | 2009 | 635 | 0.080 |
Why?
| Regional Blood Flow | 2 | 2009 | 121 | 0.080 |
Why?
| RNA, Messenger | 3 | 2006 | 1202 | 0.080 |
Why?
| Human Growth Hormone | 1 | 2007 | 51 | 0.080 |
Why?
| Herpesvirus 4, Human | 1 | 2007 | 38 | 0.080 |
Why?
| Virus Activation | 1 | 2007 | 30 | 0.080 |
Why?
| Insulin-Like Growth Factor I | 1 | 2007 | 137 | 0.070 |
Why?
| Glucose Transporter Type 3 | 1 | 2006 | 4 | 0.070 |
Why?
| Glucose Transporter Type 5 | 1 | 2006 | 5 | 0.070 |
Why?
| Glucose Transporter Type 4 | 1 | 2006 | 23 | 0.070 |
Why?
| Glucose Transporter Type 1 | 1 | 2006 | 16 | 0.070 |
Why?
| Biological Transport | 1 | 2007 | 195 | 0.070 |
Why?
| Ubiquitin | 2 | 2003 | 51 | 0.070 |
Why?
| Amino Acids, Branched-Chain | 1 | 2007 | 44 | 0.070 |
Why?
| Metabolic Diseases | 1 | 2006 | 44 | 0.070 |
Why?
| Health | 1 | 2006 | 29 | 0.070 |
Why?
| Rest | 1 | 2006 | 68 | 0.070 |
Why?
| Aged, 80 and over | 4 | 2021 | 3431 | 0.070 |
Why?
| Alanine | 1 | 2004 | 44 | 0.060 |
Why?
| Hospitalization | 1 | 2009 | 705 | 0.060 |
Why?
| Texas | 1 | 2004 | 160 | 0.060 |
Why?
| Reference Values | 1 | 2004 | 354 | 0.060 |
Why?
| Inulin | 1 | 2003 | 7 | 0.060 |
Why?
| Veins | 1 | 2004 | 74 | 0.060 |
Why?
| Arteries | 1 | 2004 | 101 | 0.060 |
Why?
| Physical Fitness | 2 | 2018 | 69 | 0.060 |
Why?
| Electric Impedance | 1 | 2023 | 43 | 0.060 |
Why?
| Immunohistochemistry | 1 | 2006 | 1089 | 0.060 |
Why?
| Multienzyme Complexes | 1 | 2003 | 41 | 0.060 |
Why?
| Critical Illness | 1 | 2006 | 344 | 0.060 |
Why?
| Osmolar Concentration | 1 | 2003 | 83 | 0.060 |
Why?
| Polyesters | 1 | 2022 | 5 | 0.060 |
Why?
| Cysteine Endopeptidases | 1 | 2003 | 75 | 0.060 |
Why?
| Wounds and Injuries | 1 | 2006 | 321 | 0.050 |
Why?
| Comorbidity | 1 | 2004 | 663 | 0.050 |
Why?
| Carbohydrates | 1 | 2022 | 64 | 0.050 |
Why?
| Apoptosis | 2 | 2010 | 1300 | 0.050 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2003 | 131 | 0.050 |
Why?
| Prognosis | 2 | 2020 | 2118 | 0.050 |
Why?
| History, 20th Century | 1 | 2022 | 114 | 0.050 |
Why?
| Muscles | 1 | 2022 | 114 | 0.050 |
Why?
| Arkansas | 2 | 2020 | 2100 | 0.050 |
Why?
| Cattle | 1 | 2021 | 224 | 0.050 |
Why?
| Incidence | 1 | 2004 | 1082 | 0.050 |
Why?
| Fibrosis | 1 | 2022 | 208 | 0.050 |
Why?
| Glycogen | 1 | 2021 | 45 | 0.050 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 2018 | 434 | 0.050 |
Why?
| Meat | 1 | 2021 | 59 | 0.050 |
Why?
| Knee Joint | 1 | 2022 | 177 | 0.050 |
Why?
| Urine | 1 | 2021 | 35 | 0.050 |
Why?
| Plant Proteins | 1 | 2021 | 72 | 0.050 |
Why?
| Food, Fortified | 1 | 2021 | 33 | 0.050 |
Why?
| Neoplasms | 1 | 2011 | 1316 | 0.050 |
Why?
| Mitochondrial Dynamics | 1 | 2020 | 22 | 0.050 |
Why?
| Ceramides | 1 | 2020 | 32 | 0.050 |
Why?
| Geriatric Assessment | 1 | 2021 | 126 | 0.050 |
Why?
| Endothelial Cells | 1 | 2022 | 294 | 0.050 |
Why?
| Prospective Studies | 2 | 2020 | 2604 | 0.050 |
Why?
| Phospholipids | 1 | 2020 | 63 | 0.050 |
Why?
| Metabolic Clearance Rate | 1 | 2019 | 75 | 0.050 |
Why?
| Protein Kinases | 1 | 2020 | 89 | 0.040 |
Why?
| Algorithms | 1 | 2004 | 697 | 0.040 |
Why?
| Respiratory Function Tests | 1 | 2020 | 98 | 0.040 |
Why?
| Anthropometry | 1 | 2020 | 96 | 0.040 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2020 | 176 | 0.040 |
Why?
| Statistics, Nonparametric | 2 | 2011 | 232 | 0.040 |
Why?
| Molecular Probe Techniques | 1 | 2019 | 9 | 0.040 |
Why?
| Fruit | 1 | 2020 | 143 | 0.040 |
Why?
| Deuterium | 1 | 2019 | 41 | 0.040 |
Why?
| Lipid Metabolism | 1 | 2020 | 194 | 0.040 |
Why?
| Evaluation Studies as Topic | 1 | 2019 | 107 | 0.040 |
Why?
| Child | 5 | 2012 | 7341 | 0.040 |
Why?
| Intestinal Absorption | 1 | 2019 | 60 | 0.040 |
Why?
| Myogenin | 1 | 2018 | 6 | 0.040 |
Why?
| PAX7 Transcription Factor | 1 | 2018 | 11 | 0.040 |
Why?
| Ileum | 1 | 2019 | 102 | 0.040 |
Why?
| Oxygen Consumption | 1 | 2019 | 223 | 0.040 |
Why?
| Glucose Intolerance | 2 | 2008 | 28 | 0.040 |
Why?
| Acute Disease | 1 | 2019 | 403 | 0.040 |
Why?
| Lower Extremity | 2 | 2009 | 103 | 0.040 |
Why?
| Gene Expression Profiling | 1 | 2003 | 1138 | 0.040 |
Why?
| Severity of Illness Index | 1 | 2020 | 1084 | 0.040 |
Why?
| Athletic Performance | 1 | 2017 | 46 | 0.040 |
Why?
| Pilot Projects | 1 | 2020 | 808 | 0.040 |
Why?
| Interleukin-6 | 2 | 2010 | 315 | 0.040 |
Why?
| Blotting, Western | 2 | 2010 | 683 | 0.030 |
Why?
| Outpatient Clinics, Hospital | 1 | 2015 | 44 | 0.030 |
Why?
| Random Allocation | 1 | 2015 | 312 | 0.030 |
Why?
| Hospitals, University | 1 | 2015 | 89 | 0.030 |
Why?
| Disease Susceptibility | 1 | 2015 | 95 | 0.030 |
Why?
| Early Diagnosis | 1 | 2015 | 96 | 0.030 |
Why?
| Creatine | 1 | 2014 | 38 | 0.030 |
Why?
| Treatment Outcome | 3 | 2011 | 5604 | 0.030 |
Why?
| Caffeine | 1 | 2014 | 77 | 0.030 |
Why?
| Reoperation | 1 | 2015 | 454 | 0.030 |
Why?
| 14-alpha Demethylase Inhibitors | 1 | 2012 | 2 | 0.030 |
Why?
| Acute-Phase Proteins | 1 | 2012 | 25 | 0.030 |
Why?
| Adipose Tissue | 1 | 2014 | 207 | 0.030 |
Why?
| Gene Expression Regulation | 2 | 2010 | 1062 | 0.030 |
Why?
| Predictive Value of Tests | 1 | 2015 | 1048 | 0.030 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2003 | 474 | 0.030 |
Why?
| United States | 1 | 2021 | 5217 | 0.020 |
Why?
| Amino-Acid N-Acetyltransferase | 1 | 2010 | 3 | 0.020 |
Why?
| Protein Modification, Translational | 1 | 2009 | 3 | 0.020 |
Why?
| Hypertrophy | 1 | 2009 | 52 | 0.020 |
Why?
| Cholesterol, VLDL | 1 | 2008 | 3 | 0.020 |
Why?
| Antifungal Agents | 1 | 2012 | 363 | 0.020 |
Why?
| Down-Regulation | 1 | 2010 | 388 | 0.020 |
Why?
| Longitudinal Studies | 1 | 2011 | 746 | 0.020 |
Why?
| Muscle Strength Dynamometer | 1 | 2008 | 12 | 0.020 |
Why?
| Cholesterol | 1 | 2008 | 155 | 0.020 |
Why?
| Movement | 1 | 2008 | 111 | 0.020 |
Why?
| Space Simulation | 1 | 2007 | 2 | 0.020 |
Why?
| Virus Latency | 1 | 2007 | 46 | 0.020 |
Why?
| Saliva | 1 | 2007 | 63 | 0.020 |
Why?
| Gait | 1 | 2008 | 98 | 0.020 |
Why?
| Case-Control Studies | 1 | 2010 | 1228 | 0.020 |
Why?
| Aerobiosis | 1 | 2006 | 16 | 0.020 |
Why?
| Actins | 1 | 2006 | 132 | 0.020 |
Why?
| Hypertension, Renal | 1 | 2005 | 22 | 0.020 |
Why?
| Anti-Inflammatory Agents | 1 | 2007 | 175 | 0.020 |
Why?
| Malondialdehyde | 1 | 2005 | 63 | 0.020 |
Why?
| Interleukin-1 | 1 | 2005 | 107 | 0.020 |
Why?
| Peptide Fragments | 1 | 2006 | 242 | 0.020 |
Why?
| Blood Proteins | 1 | 2005 | 100 | 0.020 |
Why?
| Interleukin-10 | 1 | 2005 | 107 | 0.020 |
Why?
| Follow-Up Studies | 1 | 2011 | 2387 | 0.020 |
Why?
| Stress, Psychological | 1 | 2007 | 270 | 0.020 |
Why?
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 1 | 2003 | 6 | 0.020 |
Why?
| Diet, Protein-Restricted | 1 | 2003 | 8 | 0.020 |
Why?
| Acidosis | 1 | 2003 | 38 | 0.010 |
Why?
| Food Additives | 1 | 2003 | 9 | 0.010 |
Why?
| Complement System Proteins | 1 | 2003 | 55 | 0.010 |
Why?
| Organic Chemicals | 1 | 2003 | 16 | 0.010 |
Why?
| Protein Array Analysis | 1 | 2003 | 28 | 0.010 |
Why?
| Caspases | 1 | 2003 | 146 | 0.010 |
Why?
| Combined Modality Therapy | 1 | 2003 | 692 | 0.010 |
Why?
| Retrospective Studies | 1 | 2011 | 6432 | 0.010 |
Why?
| Child, Preschool | 1 | 2003 | 4147 | 0.010 |
Why?
|
|
Ferrando's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|